Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
21.5 HKD | +2.87% | +8.37% | +5.13% |
Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.13% | 8.36B | |
+14.88% | 69.29B | |
+5.20% | 8.16B | |
-20.43% | 7.69B | |
+0.73% | 4.53B | |
+16.98% | 4.47B | |
-2.00% | 3.99B | |
-2.89% | 3.88B | |
+21.87% | 3.66B | |
+5.38% | 3.3B |
- Stock Market
- Equities
- 1099 Stock
- News Sinopharm Group Co. Ltd.
- Market Chatter: Hungary Plans $193 Million Plant to Produce Sinopharm COVID-19 Vaccines